Table 1 Clinical characteristics of study subjects
From: Plasma metabolites associated with arterial stiffness in patients with type 2 diabetes
| Â | The first dataset | The second dataset |
|---|---|---|
Number of subjects | 209 | 31 |
Age (years) | 60.5 ± 11.5 | 63.9 ± 10.5 |
Male (sex) (n, %) | 121 (57.9) | 13 (41.9) |
Diabetes duration (years) | 13.9 ± 9.9, n = 206 | 16.8 ± 11.1 |
HbA1c (%) | 9.0 ± 1.9 | 9.1 ± 2.1 |
FPG (mg/dL) | 154 ± 53, n = 205 | 145 ± 46 |
Obesity (n, Â %) | 134 (64.1) | 21 (67.7) |
BMI (kg/m2) | 27.2 ± 5.4 | 26.7 ± 5.1 |
Hypertension (n, %) | 138 (66.0) | 22 (71.0) |
Systolic BP (mmHg) | 126 ± 18 | 129 ± 17 |
Dyslipidemia (n, %) | 137 (65.6) | 26 (83.9) |
Total cholesterol (mg/dL) | 198 ± 50 | 201 ± 61 |
HDL cholesterol (mg/dL) | 49 ± 15 | 53 ± 12 |
LDL cholesterol (mg/dL) | 114 ± 39 | 120 ± 49 |
Triglyceride (mg/dL) | 182 ± 143 | 157 ± 97 |
eGFR (mL/min/1.73 m2) | 73 ± 24 | 71 ± 21 |
Smoking history (n, %) | 109 (52.2), n = 208 | 15 (48.4) |
Medication use | ||
 Diabetes (n, %) | 178 (85.2) | 26 (83.9) |
 Hypertension (n, %) | 127 (60.8) | 19 (61.3) |
 Dyslipidemia (n, %) | 99 (47.4) | 22 (71.0) |
baPWV (cm/s) | 1728 ± 384 | 1813 ± 275 |